Skip to main content

Immunotherapy (Checkpoint Inhibitor)

28 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Immunotherapy (Checkpoint Inhibitor) (28)

Toripalimab

Immunotherapy (Checkpoint Inhibitor)

Therapeutic Category

Immunotherapy (Checkpoint Inhibitor)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Anti-PD-1 mAb

Zalifrelimab

Immunotherapy (Checkpoint Inhibitor)

Therapeutic Category

Immunotherapy (Checkpoint Inhibitor)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Anti-CTLA-4 mAb

Zimberelimab

Immunotherapy (Checkpoint Inhibitor)

Therapeutic Category

Immunotherapy (Checkpoint Inhibitor)

Oncology Type

Both (Solid & Hematologic)

Drug Class / Mechanism

Anti-PD-1 mAb

Sugemalimab

Immunotherapy (Checkpoint Inhibitor)

Therapeutic Category

Immunotherapy (Checkpoint Inhibitor)

Oncology Type

Solid Tumour

Drug Class / Mechanism

Anti-PD-L1 Monoclonal Antibody